MagmaMAX-I

Tirzepatide
1 vials x 10 mg

  • Reduces appetite

  • Supports weight loss

  • Helps regulate blood sugar

  • Activates GIP and GLP‑1 receptors

MagmaMAX-I (Tirzepatide) is a synthetic, single-molecule, multi-receptor peptide consisting of 39 amino acids, engineered to possess dual agonism against the glucose-dependent insulinotropic polypeptide (GIP) receptor and the GLP-1 receptor. It contains a C20 fatty diacid moiety attached via a linker to the Lys20 residue, giving it a prolonged plasma half-life of roughly 5 days. Its dual affinity targets both receptors, where its GIP receptor activity outpaces its GLP-1 receptor activity, optimizing energy
homeostasis, fat oxidation, and islet cell survival far beyond mono-agonist variants.

95%

POPULARITY

Weight-Loss Effect
Muscle Gain
Treatment Discontinuation
Weight Regain After Stopping

Do you want to check your product ? Click Here
See Other Products

HUMAXPHARMA

Humaxpharma does not ship to countries, which classify these pharmaceuticals as special controlled or scheduled substances, including but not limited to the United States, Australia, Canada and Europe. We do not sell any products online. We do not sale to the public.
We are not directly or indirectly associated with any websites that may engage in selling same or similar products. Information contained within this website is not a prescription to use and is intended for information purposes only.

Please Note: This website is not an online store. Website does not have a shopping cart or e-commerce features. We do not sell or ship to the USA, Europe, Australia or any other locations where prohibited.

This will close in 20 seconds